Summary of Singapore Medical Device Regulation changes (HSA briefing on 28 February 2018)

March 21, 2018

At the latest HSA briefing held on 28 Feb 2018, it was announced that a revised regulation is targeted to be rolled out in June or July 2018.


With the revised regulation, here are the following changes: 


For Changes in Regulatory Requirements for Class A Medical Device (MD) after the revised regulation is implemented 

  • All Class A MD (includes Sterile) are not required for registration. 

  • Only notification is required and dealers have to do it by listing them in Class A database, prior to import/supply

  • For solely Class A MD dealers, only DoC to QMS is required. 3rd Party Audit and

  • Certification is not required anymore. QMSCAD will be obsoleted too.

  • The draft will be published for comment in March/April.


For Changes in Regulatory Requirements for Class B MD after the revised regulation is implemented

  • There will be no EBR-1 and EBR-2, they will be lumped under Immediate Class B Evaluation Route (IBR).  

    • Requirement for IBR include: 

      • No safety issues globally and with 2 reference regulatory agencies approval  


      • No safety issues globally with 1 reference agency and 3 years marketing history.


For Standalone Mobile Medical Device Applications 

  • Both Class B and Class C of Standalone Mobile MD will qualify for Immediate Registration Route if the device is reviewed and approved by 1 reference regulatory agencies and no safety issues globally  


For Devices for Wellness Purpose 

  • Telehealth Products that is not intended for medical purposes has to indicate "intended for wellness purpose"


For Devices for Aesthetic Purpose

  • HSA is focusing their regulatory oversight on high risk devices under this category. 

    • High risk devices are those 

      • with known or reported serious adverse events globally 

      • pose comparable risks to other regulated medical devices (e.g. foreseeable hazards)

  • List of high risk devices intended for aesthetics-related purposes only that will be regulated as medical devices 

    • Any implant for the modification or fixation of any body part (e.g breast implant, gluteal implant)

    • Any injectable dermal or mucous membrane filler (e.g. soft tissue fillers, wrinkle fillers)

    • Any instrument, apparatus, implement, machine or appliance intended to be used for the removal or degradation of fat by invasive means. (e.g. liposuction devices)

  • Devices intended for aesthetic-related purposes that also have medical claims are already regulated as medical devices.

    • Hence the devices in the positive list are currently subject to MD regulatory controls.

  • Where devices intended solely for aesthetics-related purpose are not within the high risk list of devices to be regulated as medical devices (cryolipolysis equipment, laser devices for skin tightening) 

    • Some of these devices will still be subject to other local regulatory controls (e.g. NEA controls) Where applicable

    • No impediment to market access 

    • Operational details on any follow-up actions required from dealers will be communicated at a later date.


For Trained User Only (TUO) MD

  • This category will be introduced due to a Medical Device Reporting (MDR) that happened in the United States of America where deaths were reported. The device involved was meant to be used by non-doctors.

  • The manufacturers will have to indicate the intended user and determine if training is required for the user to become a "trained user".

  • Unlike Professional Use Only Devices, TUO will not have additional registration condition.


For Change Notification

  • An updated guidance which include industry feedback from the previous focus group session will be published for public consultation. 


Contact us at



Please reload

Recent Posts
Please reload

  • LinkedIn - White Circle
  • YouTube - White Circle
  • Twitter - White Circle
  • LinkedIn - White Circle
  • YouTube - White Circle
  • Twitter - White Circle



Call us:

   : +65 6909 0396

   : +65 9067 1432


Email us:


© 2018 ARQon All Rights Reserved. 

  • LinkedIn - White Circle
  • YouTube - White Circle
  • Twitter - White Circle